Wu et al. reported greater tumour growth inhibiton in US+CA+aPD-L1-treated tumours than in the US+CA group and aPD-L1 group, and the combination therapy resulted in a substantial increase in activated CD8+ T cell infiltration [43]. This evidence concerns the gene CD8A and neoplasm.